[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$mlys

$MLYS sees mixed sentiment as $AZN's positive trial results are announced, while traders recommend $MLYS for potential gains.

About $mlys

A financial asset, likely a stock or cryptocurrency, identified by the ticker symbol $mlys.

Insights #

$mlys Engagements hit a high of XXXXXX for the day
$mlys Engagements hit an all time of XXXXXX for the day

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Month: XXXXXX -XX%
1-Year High: XXXXXX on 2025-07-14
1-Year Low: XXX on 2025-07-13

Social Network	X
Engagements	XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +592%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27

Social Network	X
Mentions	XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $mlys in the last XX hours which is up XXXX% from XX in the previous XX hours Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +1,307%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-04-27

The most influential creators that mention $mlys in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@semodough	X	XXXXXX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XXX%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-04-28
1-Year Low: XX% on 2025-07-19

Most Supportive Themes

Positive Trading Recommendations: (60%) Several posts highlight potential gains from trading $MLYS, often in conjunction with other stocks, suggesting positive sentiment from some traders.
Sector Interest and Comparisons: (20%) Mentions of $MLYS alongside $AZN and other pharmaceutical companies, indicating interest in the sector and potential comparisons.

Most Critical Themes

Negative Analyst Sentiment: (20%) Jefferies has a negative view on $MLYS, citing potential commercial success challenges compared to $AZN.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXXXX	XX%	X	X%

Total	XXX	XX%	XXXXX	XX%	X	X%

Top assets mentioned In the posts about $mlys in the last XX hours

AstraZeneca PLC (AZN) SPX6900 (SPX) Novartis AG (NVS) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Nuvalent, Inc. Class A Common Stock (NUVL) Avidity Biosciences, Inc. Common Stock (RNA) Geron Corp (GERN) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)

Top topics mentioned In the posts about $mlys in the last XX hours

stocks, stocks healthcare, coins layer 1, coins defi, $azn, coins arbitrum, manat, coins solana ecosystem, coins made in usa, stocks consumer cyclical, stocks financial services, coins gaming, stocks energy, stocks communication services, stocks industrials, qqq, spx, $qqq, $spx, $nvs, stocks technology, $lly, eli lilly, coins dao, coins nft, stocks bitcoin treasuries, coins meme, coins bsc, $mltx, $nuvl, $urgn, coins pow, $rxst, $spry, $wve, $nams, $rna, $gern, $mdgl, $cycc, coins base ecosystem, stocks consumer defensive, coins bitcoin ecosystem, stocks real estate, $srrk, $lrmr, $gpcr, $celc, $eols, $rzlt, $cldx, devs, $devs, $tecx, $akro, $imnm, $srpt, $anab, $zyme, sec, $iron, $bcax, $tyra, $dyn, $lenz, $sion, $etnb, $asnd, $pcvx, $rytm, $janx, $aclx, $ewtx, dyne therapeutics, sarepta therapeutics inc, $cybn, $nktr, $rare, $prax, $krys, superrare, superrarebears, $bbio, $rvmd, $vtyx, $tara, $fdmt, $avtx, $eras, taraxa, $trml, $imcr, $insm, $imvt, $dnli, $prok, $ftft, telo, $autl, $uavs